Document is current
Any future updates will be listed below
-
Authors
Dumontet, Typhanie https://orcid.org/0000-0002-1328-9515
Basham, Kaitlin J.
Foster, Micah C. https://orcid.org/0009-0002-3139-1502
Silverman, Emma
Heard, Kyle A.
Johnson, Dominque
Lee, Chaelin
Plaska, Samuel W.
Breault, David T. https://orcid.org/0000-0002-0402-4857
Penton, David https://orcid.org/0000-0002-6425-3766
Beuschlein, Felix https://orcid.org/0000-0001-7826-3984
Turcu, Adina F.
LaPensee, Christopher R.
Marcondes Lerario, Antonio https://orcid.org/0000-0002-8336-6432
Hammer, Gary D. https://orcid.org/0000-0001-6843-3628
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 17 December 2025
First Online: 11 January 2026
Competing interests
: G.D.H. Founder and Board of Directors—Sling Therapeutics, Advisor—Orphagen Pharmaceuticals. The remaining authors declare no competing interests.
